Products & Services · Total revenues
Total Rare — Total revenues
Alnylam Pharmaceuticals Total Rare — Total revenues decreased by 7.9% to $125.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.3%, from $109.06M to $125.72M. Over 2 years (FY 2023 to FY 2025), Total Rare — Total revenues shows an upward trend with a 23.3% CAGR.
Analysis
Metric ID:
alny_segment_total_rare_total_revenuesHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.27M | $82.27M | $82.27M | $82.27M | $100.71M | $102.74M | $111.26M | $108.22M | $109.06M | $127.72M | $126.7M | $136.44M | $125.72M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +22.4% | +2.0% | +8.3% | -2.7% | +0.8% | +17.1% | -0.8% | +7.7% | -7.9% |
| YoY Change | — | — | — | — | +22.4% | +24.9% | +35.2% | +31.5% | +8.3% | +24.3% | +13.9% | +26.1% | +15.3% |
Range$82.27M – $136.44M
CAGR+15.2%
Avg YoY Growth+22.4%
Median YoY Growth+24.3%
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's total rare — total revenues?
- Alnylam Pharmaceuticals (ALNY) reported total rare — total revenues of $125.72M in Q1 2026.
- How has Alnylam Pharmaceuticals's total rare — total revenues changed year-over-year?
- Alnylam Pharmaceuticals's total rare — total revenues increased by 15.3% year-over-year, from $109.06M to $125.72M.
- What is the long-term trend for Alnylam Pharmaceuticals's total rare — total revenues?
- Over 2 years (2023 to 2025), Alnylam Pharmaceuticals's total rare — total revenues has grown at a 23.3% compound annual growth rate (CAGR), from $329.09M to $499.92M.